Not long ago, supportive care and mobility aids were all medical science could offer people living with neuromuscular disease. But the treatment and care landscapes have begun to change dramatically. Recent breakthroughs in genetic medicine, along with other discoveries, are accelerating the development of new therapies, including some that not just address symptoms but also — for the first time — directly modify the underlying disorders.
As the largest and longest-established organization for people with neuromuscular diseases, the Muscular Dystrophy Association (MDA) works tirelessly on the community’s behalf. We’ve done so for nearly seven decades. Now, with growing scientific knowledge and the expansion of improved treatment options come new ways for us to transform the lives of people with muscular dystrophy, ALS, and related neuromuscular disease through innovations in science and innovations in care.
Click here to read about this new era in neuromuscular disease and learn how MDA is changing with changing times.